Main Article Content
Objective: check comparison between the efficacy of single loading dose regimen and standared dose regimen of
magnesium sulphate in patients with severe pre eclampsia.
Material and Methods: This research study was coordinated at Department of Gynecology and Obstetrics, Lady
Reading Hospital Peshawar-Pakistan. The period of this study was one year from April 2016 to April 2017. Study design
was randomized control trial in which a total of 256 patients in each group, taking proportion of efficacy of loading dose
85% and efficacy of standered dose 92%2, 5% level of significance, 80% power of test and 95% confidence interval.
Moreover, all patients with severe pre eclampsia, gestational age > 20 weeks, patients age 20-40 years,with patients
having singleton pregnancy while mild to moderate pre eclampsia, gestational age < 20 weeks, multiple pregnancy
were excluded. In this study the total patients were divided into two groups, group A: receiving loading dose magnesium
sulphate therapy and group B: receiving standard magnesium sulphate therapy. Gestation was confirmed by
early available ultrasound in the first trimester or by her last menstrual period date. Good blood pressure control was
a key step in both groups. All women in both groups were followed after receiving magnesium sulphate maintenance
therapy to detect the occurrence of fits.
Results: In this mean age in Group a (loading dose regimen of magnesium sulphate) was 24.1 ± 3.24 while mean
age in Group B (standered dose regimen of magnesium sulphate therapy) was 24.96 ± 3.79. More over in this study
loading dose regimen of magnesium sulphate was effective in all the 256 patients while standeaed dose regimen of
magnesium sulphate therapy was also effective in all the 256 patients.
Conclusion: Associated with similar efficacy in controlling convulsions, the use of loading dose magnesium sulphate
protocols is a viable alternative to standard dose therapy. Further studies are requied to support its routine clinical use
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
CopyRight . © 2008-2020 Khyber Medical College Peshawar | All Rights Reserved